115 related articles for article (PubMed ID: 25530331)
1. Diagnostic category agreement and malignancy rates in clinician-categorised, non-standardised thyroid cytology reports.
Bolland MJ; Eagleton C; Orr-Walker B
N Z Med J; 2014 Dec; 127(1407):49-55. PubMed ID: 25530331
[TBL] [Abstract][Full Text] [Related]
2. [On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].
Bak M; Péter I; Nyári T; Simon P; Újlaky M; Boér A; Kásler M
Orv Hetil; 2015 Oct; 156(41):1661-6. PubMed ID: 26551169
[TBL] [Abstract][Full Text] [Related]
3. The Bethesda System for Reporting Thyroid Cytopathology is applicable to frozen section diagnosis in children.
Arnold MA; Nicol KK
Pediatr Dev Pathol; 2015; 18(2):139-45. PubMed ID: 25625563
[TBL] [Abstract][Full Text] [Related]
4. Fine needle aspiration cytology of nodular thyroid lesions: a 2-year experience of the Bethesda system for reporting thyroid cytopathology in a large regional and a university hospital, with histological correlation.
Mastorakis E; Meristoudis C; Margari N; Pouliakis A; Leventakos K; Chroniaris N; Panayiotides I; Karakitsos P
Cytopathology; 2014 Apr; 25(2):120-8. PubMed ID: 23551656
[TBL] [Abstract][Full Text] [Related]
5. A simplified Bethesda System for reporting thyroid cytopathology using only four categories improves intra- and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks.
Walts AE; Bose S; Fan X; Frishberg D; Scharre K; de Peralta-Venturina M; Zhai J; Marchevsky AM
Diagn Cytopathol; 2012 May; 40 Suppl 1():E62-8. PubMed ID: 21557534
[TBL] [Abstract][Full Text] [Related]
6. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
Tepeoğlu M; Bilezikçi B; Bayraktar SG
Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
[TBL] [Abstract][Full Text] [Related]
7. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
[TBL] [Abstract][Full Text] [Related]
8. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology.
Jo VY; Stelow EB; Dustin SM; Hanley KZ
Am J Clin Pathol; 2010 Sep; 134(3):450-6. PubMed ID: 20716802
[TBL] [Abstract][Full Text] [Related]
9. 'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact.
Pagni F; Prada M; Goffredo P; Isimbaldi G; Crippa S; Di Bella C; Leone BE;
Cytopathology; 2014 Jun; 25(3):170-6. PubMed ID: 23937572
[TBL] [Abstract][Full Text] [Related]
10. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
[TBL] [Abstract][Full Text] [Related]
11. Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta-analysis.
Vuong HG; Ngo HTT; Bychkov A; Jung CK; Vu TH; Lu KB; Kakudo K; Kondo T
Cancer Cytopathol; 2020 Apr; 128(4):238-249. PubMed ID: 31883438
[TBL] [Abstract][Full Text] [Related]
12. The Bethesda System for Reporting Thyroid Fine-Needle Aspiration Cytology: A Kuwaiti Experience - A Cytohistopathological Study of 374 Cases.
Kapila K; Qadan L; Ali RH; Jaragh M; George SS; Haji BE
Acta Cytol; 2015; 59(2):133-8. PubMed ID: 25676743
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Inter-observer Agreement Among the Members of the Italian Consensus for the Classification and Reporting of Thyroid Cytology.
Crescenzi A; Trimboli P; Basolo F; Frasoldati A; Orlandi F; Palombini L; Papini E; Pontecorvi A; Vitti P; Zini M; Nardi F; Fadda G
Endocr Pathol; 2020 Sep; 31(3):301-306. PubMed ID: 32621106
[TBL] [Abstract][Full Text] [Related]
14. Assessment of malignancy rate in thyroid nodules according to the Bethesda system of fine-needle aspiration. Report from a tertiary center in the Southwestern region of Saudi Arabia.
Al-Shraim MM; Kaood OM; Hussein MR; Al-Ahmary AM; Al Shehri GY; Jastania RA; Mahfouz AA; Abu-Eshy SA
Saudi Med J; 2012 Feb; 33(2):167-71. PubMed ID: 22327757
[TBL] [Abstract][Full Text] [Related]
15. Fine needle aspiration of thyroid nodules in the pediatric population: a 12-year cyto-histological correlation experience at North Shore-Long Island Jewish Health System.
Lale SA; Morgenstern NN; Chiara S; Wasserman P
Diagn Cytopathol; 2015 Aug; 43(8):598-604. PubMed ID: 25728981
[TBL] [Abstract][Full Text] [Related]
16. The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, "risk" of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions.
Crowe A; Linder A; Hameed O; Salih C; Roberson J; Gidley J; Eltoum IA
Cancer Cytopathol; 2011 Oct; 119(5):315-21. PubMed ID: 21751427
[TBL] [Abstract][Full Text] [Related]
17. Outcome and diagnostic reproducibility of the thyroid cytology "indeterminate categories" SIAPEC/SIE 2014 in a consecutive series of 302 cases.
Massa F; Caraci P; Sapino A; De Rosa G; Volante M; Papotti M
J Endocrinol Invest; 2021 Apr; 44(4):803-809. PubMed ID: 32797379
[TBL] [Abstract][Full Text] [Related]
18. Trends in Thyroid Fine-Needle Aspiration Cytology Practices: Results From a College of American Pathologists 2016 Practice Survey.
Mais DD; Crothers BA; Davey DD; Natale KE; Nayar R; Souers RJ; Blond BJ; Hackman S; Tworek JA
Arch Pathol Lab Med; 2019 Nov; 143(11):1364-1372. PubMed ID: 31100017
[TBL] [Abstract][Full Text] [Related]
19. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H
Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417
[TBL] [Abstract][Full Text] [Related]
20. Inter-observer reproducibility of the Royal College system for reporting thyroid cytology: Experience of the Egyptian National Cancer Institute.
Ezzat NE; Abusinna ES; Hafez NH; Alieldin NH
J Egypt Natl Canc Inst; 2018 Sep; 30(3):85-91. PubMed ID: 30143404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
